As of 2025-03-15, the EV/EBITDA ratio of Global Blood Therapeutics Inc (GBT) is -16.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GBT's latest enterprise value is 4,942.22 mil USD. GBT's TTM EBITDA according to its financial statements is -293.25 mil USD. Dividing these 2 quantities gives us the above GBT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 13.5x | 12.6x |
| Forward P/E multiples | 17.4x - 34.9x | 21.6x |
| Fair Price | (80.37) - (63.51) | (79.07) |
| Upside | -217.4% - -192.7% | -215.4% |
| Date | EV/EBITDA |